122 related articles for article (PubMed ID: 17363436)
1. Characteristics of the protective subcellular coccidioidal T27K vaccine.
Johnson SM; Kerekes KM; Lunetta JM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():275-89. PubMed ID: 17363436
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
3. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods.
Lunetta JM; Simmons KA; Johnson SM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():164-80. PubMed ID: 17363438
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii Cu,Zn superoxide dismutase identified by proteomic analysis of the coccidioidal T27K vaccine.
Lunetta JM; Simmons KA; Johnson SM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():181-97. PubMed ID: 17344523
[TBL] [Abstract][Full Text] [Related]
7. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).
Johnson SM; Lerche NW; Pappagianis D; Yee JL; Galgiani JN; Hector RF
Ann N Y Acad Sci; 2007 Sep; 1111():290-300. PubMed ID: 17347333
[TBL] [Abstract][Full Text] [Related]
8. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
9. The public health need and present status of a vaccine for the prevention of coccidioidomycosis.
Hector R; Rutherford GW
Ann N Y Acad Sci; 2007 Sep; 1111():259-68. PubMed ID: 17344529
[TBL] [Abstract][Full Text] [Related]
10. Immunization of mice against coccidioidomycosis with a subcellular vaccine.
Pappagianis D; Hector R; Levine HB; Collins MS
Infect Immun; 1979 Jul; 25(1):440-5. PubMed ID: 478645
[TBL] [Abstract][Full Text] [Related]
11. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis.
Capilla J; Clemons KV; Liu M; Levine HB; Stevens DA
Vaccine; 2009 Jun; 27(27):3662-8. PubMed ID: 19464548
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
13. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
14. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.
Shubitz LF; Yu JJ; Hung CY; Kirkland TN; Peng T; Perrill R; Simons J; Xue J; Herr RA; Cole GT; Galgiani JN
Vaccine; 2006 Jul; 24(31-32):5904-11. PubMed ID: 16759762
[TBL] [Abstract][Full Text] [Related]
15. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation.
Peng T; Orsborn KI; Orbach MJ; Galgiani JN
J Infect Dis; 1999 Feb; 179(2):518-21. PubMed ID: 9878042
[TBL] [Abstract][Full Text] [Related]
16. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
Walch HA; Kalvoda A
Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
[No Abstract] [Full Text] [Related]
17. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
19. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
Scalarone GM; Levine HB
Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
[No Abstract] [Full Text] [Related]
20. The present status of vaccination against coccidioidomycosis in man.
Pappagianis D; Levine HB
Am J Epidemiol; 1975 Jul; 102(1):30-41. PubMed ID: 1155435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
